inVentiv Health has expanded its compliance services to assist biopharma companies conducting non-interventional studies (NIS) or observational studies, in 52 countries around the world. Clients of the new services will have access to an NIS Regulatory Intelligence Database aimed at clarifying the new EU regulation No 536/2014, scheduled to take effect in May 2016.    Vague regulatory language around the new regulation is expected to cause confusion about the conduct of non-interventional trials...